Methylene blue compared to norepinephrine in the management of vasoplegic syndrome in pediatric patients after cardiopulmonary bypass: a randomized contr

Methylene blue compared to norepinephrine in the management of vasoplegic syndrome in pediatric patients after cardiopulmonary bypass: a randomized contr

Background and aim: Vasoplegic syndrome (VS) is a frequent complication following cardiopulmonary bypass (CPB) requiring escalating dose of vasopressor support. The guanylate cyclase inhibitor methylene blue (MB) could be an attractive alternative treatment in such cases. This study examines the eff...

Full description

Bibliographic Details
Main Authors: Raafat Abdelazim, Dina Salah, Heba A. Labib, Ashraf A. El Midany
Format: Article
Language:English
Published: Taylor & Francis Group 2016-07-01
Series:Egyptian Journal of Anaesthesia
Subjects:
Methylene blue
Vasoplegic syndrome
Online Access:http://www.sciencedirect.com/science/article/pii/S1110184916300290

Similar Items

Similar Items